Senior insider sale
Chief People Officer at ADAPTIVE BIOTECHNOLOGIES CORP — senior position signals high conviction
$2.73M
170.82K shares
What this filing means
LO FRANCIS plans to sell 170.82K shares of ADAPTIVE BIOTECHNOLOGIES CORP valued at approximately $2.73M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/8/2026ACC: 0001950047-26-003321
Officer· Chief People Officer
Since Jun 2019
170.82K
Shares to sell
$2.73M
Approx. market value
22.56K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months2
Exercise of Stock Options
Cash
4/8/2026
2.34KRestricted Stock Units
N/A
3/4/2025
20.22KTotal acquired22.56K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/8/2026 | Exercise of Stock Options Cash | 2.34K | — |
3/4/2025 | Restricted Stock Units N/A | 20.22K | — |
| Total | 22.56K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
30.59K
Market value
$430.6K
3/11/2026
—Completed
Units to sell
38.07K
Market value
$574.5K
3/5/2026
—Completed
Units to sell
79.59K
Market value
$1.41M
1/12/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
22.56K
Market value
$309.4K
4/8/2026
Total
Units
170.82K
Value
$2.73M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/11/2026 | 30.59K | $430.6K | — | Completed |
3/5/2026 | 38.07K | $574.5K | — | Completed |
1/12/2026 | 79.59K | $1.41M | — | Completed |
| Planned — Approximate Date | ||||
4/8/2026 | 22.56K | $309.4K | NASDAQ | Planned |
| Total | 170.82K | $2.73M | ||